Difference between revisions of "NM Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
m
m
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
 
Co-Chairs:  Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
 
Co-Chairs:  Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
<br />RSNA Staff Support: Julie Lisiecki
+
 
 
 
*[https://tinyurl.com/QIBA-NM-CC-Roster '''Roster''']
 
*[https://tinyurl.com/QIBA-NM-CC-Roster '''Roster''']
 
  
 
==Scope==  
 
==Scope==  
Line 19: Line 17:
 
::* I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee]
 
::* I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee]
 
::* PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee]
 
::* PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee]
 
 
==Meetings==
 
 
* Zoom calls are held Quarterly. Please contact RSNA Staff for details.
 

Latest revision as of 17:07, 17 January 2024

Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD

Scope

The NM Coordinating Committee is responsible for:

  • Monitoring and coordinating the activities of NM Biomarker Committees
  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the NM Biomarker Committees